Lupin Implements Acceliant Platform for BA/BE studies

Objective- Lupin was looking for a robust platform for their clinical studies which has a best in breed user interface and is also cost effective.

Major challenges:-

  1. Manage individual tools for normal phase of CT and BA/BE trial.
  2. For each trial, separate discussion for pricing and maintain individual documents. Also, they will have to be cautious with the number of pages and subjects.
  3. We’re outsourcing their current technology, wanted an easy to use platform for internal team

Benefits-

  1. No restriction (unlimited pages, sites, subjects and 100 trials/year)
  2. Feature rich (So many features facilitates the data collection and review).
  3. Can create trial independently.
  4. If required, can derive the workflow in Acceliant like blood sample collection time entry.

CONTACT US TODAY

By submitting your information, you agree to our revised Privacy Policy.

Share this post

You might also like...

Acceliant Transforms one of the largest eClinical Studies

Objective

A leading Fortune 500 pharma multinational in US was looking for an EDC solution for their late phase Immunology and infectious disease TA. Since the quantum of trial Parameter was enormous, the client wanted to have...

Continue Reading >

Watch: How we add value

Want to know more? Talk to us.

Contact us+1-408-387-5800